Skip to main content
. 2012 Nov 1;69(4):1–10. doi: 10.1007/s00228-012-1424-1

Fig. 9.

Fig. 9

Spain. There was a substantial increase in BZD and Z-drug consumption between 2005 and 2011 and PR-melatonin was not on the market